The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: September 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next

Whiteley, A.E., Ma, D. et al. Science. 384, 6702 (2024).
doi: 10.1126/science.adh5548.

Summary of the findings

Breast cancer cell (BCC) metastasis to the leptomeninges (LM), the cerebrospinal fluid (CSF)-containing membranes surrounding the brain and spinal cord, is a rapidly fatal disease complication. Despite recent advances in treating brain parenchymal metastasis, standard of care for LM disease (LMD) has remained essentially unchanged for decades. The paucity of targeted molecular therapies to treat LMD is attributed to our poor understanding of the molecular mechanisms governing LM metastasis and the narrow toxicity window of the nervous system.

In this article, the authors show that bone-metastatic BCCs can bypass the blood-brain and blood-CSF barriers and invade the LM along the abluminal surface of emissary vessels connecting the bone marrow to the central nervous system. This process, dependent on BCC α6 integrin-laminin interactions with the vascular basement membrane, is a novel and efficient route of solid tumor LM metastasis. Once in the LM, BCCs are exposed to a tissue niche that is at once a harsh environment for tumor growth due to relative nutrient deprivation and a “sanctuary site” of therapeutic resistance. Little is understood about the role the immune system plays in disease control or tumor promotion in the LM. The authors’ new data shed light on these interactions. Using intravital microscopy, they show that BCCs in the LM are encased by perivascular macrophages that secrete the protective neurotrophin, GDNF, activating NCAM-dependent cell survival pathways in BCCs. This process mimics GDNF/macrophage developmental and neuroprotective pathways and highlights the cunning mechanisms tumors cells can invoke to metastasize successfully.

.
BCCs that have metastasized to the bone marrow of the skull or vertebrae and that express the laminin receptor, integrin α6, bind to laminin present in the vascular basement membrane matrix of emissary vessels. These specialized vessels pass from the bone marrow through fenestrations in the cortical bone and emerge on the other side as LM vasculature, thereby directly bridging the bone marrow and LM microenvironments. Integrin a6-laminin interactions activate BC migration along the external/abluminal surface of these emissary vessels, promoting BCC invasion along these “guidewire” vessels linking the bone marrow to the LM. Once in the meninges, BCCs co-localize with perivascular meningeal macrophages and stimulate these to secrete glial cell-derived neutrophic factor (GDNF). Through interactions with neural cell adhesion molecule (NCAM) receptors on BCCs, GDNF stimulates cell survival signaling pathways and promotes BC growth in the LM.

Future impact

Identifying patients at risk for LMD and developing novel targeted therapies to prevent and treat LM invasion could have significant impact on patient outcomes. This study identifies a new pathway for BC invasion into the LM and mechanisms whereby BCCs subvert the immune system to promote their survival in this microenvironment. These data reveal potential biomarkers and therapeutic targets for future drug development.
.
Read more in Science

8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

VIDEO |  How to get through “failure” in a research career

VIDEO | How to get through “failure” in a research career

October 16, 2025

Click above to watch At the Early Career Researchers’ Conference 2025, we enjoyed a brilliant programme of diverse sessions from a range of experts, including Joan...

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

July 16, 2025

Dr. Alexandra Boitor, EACR Scientific Officer, gives a few of the highlights from Cancer Researchers to Watch: An early career showcase (Lisbon, 15-16 June 2025). The EACR's...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: July 2025

October 17, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast
Podcast

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast

November 7, 2025
“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship
Community

“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship

November 5, 2025
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

Table of Contents

×
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
    • Summary of the findings
    • Future impact
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
→ Table of Contents
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR